KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$310.84
+1.90%Margins
Gross margin
93.4%
EBITDA margin
53.7%
EBIT margin
48.4%
Net margin
47.9%
FCF margin
66.0%
15.7%
Return on equity
14.2%
Return on assets
15.8%
Return on invested capital
0.30x
Asset turnover
$323.9M
Cash from operations
$31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026